pharma · Clear Cell Renal Cell Carcinoma · Cushing s Syndrome
Peking University Biologics
Peking University Third Hospital
Peking University Biologics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
仙霞路, 319号, 上海市, 长宁区, CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 仙霞路, 319号, 上海市, 长宁区, CN
- Founded
- 2018
- Employees
- 8
- Programs
- 15
- Drugs
- 25
- Patents
- 0
Peking University Biologics clinical trials
Registry index of 15 ClinicalTrials.gov studies linked to Peking University Biologics programs — each row shows trial ID, program name, phase, status, and indication.
Peking University Biologics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Peking University Biologics.
-
recombinant human endostatin — Phase 2
Clinical update -
Protocol-based management of perioperative antithrombotic therapy — Unknown
Clinical update -
Glofitamab — Phase 2
Clinical update -
ERA — Unknown
Clinical update -
Dexmedetomidine — Approved
Clinical update -
Combination of targeted biopsy and systematic biopsy — Unknown
Clinical update -
chlorhexidine acetate gargle — Unknown
Clinical update -
Triptolide Wilfordii — Phase 3
Clinical update